US Patent 7393958 Triamide-substituted heterobicyclic compounds
Patent 7393958 was granted and assigned to Pfizer on July, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Derek L. Tickner0
Ernest S. Hamanaka0
Marcus D. Ewing0
Michel A. Couturier0
Peter Bertinato0
Ralph P. Robinson0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+86 characters)
Article
Patent abstract
This invention relates to MTP/Apo-B secretion inhibitors of Formula (I)
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07393958 Triamide-substituted heterobicyclic compounds US Patent 7393958 Triamide-substituted heterobicyclic compounds
Infobox
Patent Number
07393958
Patent Number
7393958
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07393958 Triamide-substituted heterobicyclic compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07393958
Date of patent
July 1, 2008
Patent application number
11554351
Date Filed
October 30, 2006
Patent primary examiner
Find more entities like US Patent 7393958 Triamide-substituted heterobicyclic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
